Analysis of the prevalence of von Hippel-Lindau Syndrome in patients with hemangioblastomas of the Central Nervous System
DOI:
https://doi.org/10.33448/rsd-v11i2.26018Keywords:
Hemangioblastoma; Von Hippel-Lindau syndrome; Prevalence.Abstract
Hemangioblastomas (HBs) are benign neoplasms commonly located in the cerebellum and spinal cord and may arise sporadically or related to von Hippel-Lindau Syndrome (VHL). When there is an association with VHL, multifocal tumors may arise, unlike sporadic tumors, which are isolated. VHL is a hereditary disease related to the development of benign and malignant tumors, the most common being central nervous system hemangioblastomas and retinal angiomas. The disease is caused by the inefficacy of the Tumor Suppressor Gene VHL (pVHL) in an allolo on chromosome 3p25-26. The presence of VHL in patients with HBs leads the patient to a worse prognosis, as it facilitates metastatization. Thus, the aim of the following review is to analyze the prevalence of von Hippel-Lindau syndrome in patients with central nervous system (CNS) hemangioblastomas. This is a systematic bibliographic review that used the PubMed, SciELO and Google Scholar platforms as databases for research of scientific articles, with a time frame between 2016 and 2022, in English. According to the search engine, 4 results were found after the exclusion criteria in the PubMed and Google Scholar databases. It was found, therefore, that there is a moderate prevalence of HLV in patients with CNS HBs. Among the studies, the lowest prevalence rate of HlV in patients with HBs was 23%, while the highest rate was approximately 60%, with an overall average of ± 39.2%, when considering all studies involving these patients.
References
Ammerman, J. M., Lonser, R. R., Dambrosia, J., Butman, J. A., & Oldfield, E. H. (2006). Long-term natural history of hemangioblastomas in patients with von Hippel–Lindau disease: implications for treatment. Journal of neurosurgery, 105(2), 248-255.
Cervio, A., Villalonga, J. F., Liñares, J. M., Mormandi, R., Condomí Alcorta, S., & Salvat, J. (2015). Tratamiento quirúrgico de los hemangioblastomas del sistema nervioso central. Rev Argent Neuroc, 29(3), 117-131.
Cheng, J., Liu, W., Zhang, S., Lei, D., & Hui, X. (2017). Clinical features and surgical outcomes in patients with cerebellopontine angle hemangioblastomas: retrospective series of 23 cases. World neurosurgery, 103, 248-256.
Chittiboina, P., & Lonser, R. R. (2015). Doença de Von Hippel-Lindau. Manual de neurologia clínica, 132, 139–156. https://doi.org/10.1016/B978-0-444-62702-5.00010-X
Findeis-Hosey, J. J., McMahon, K. Q., & Findeis, S. K. (2016). Von hippel–lindau disease. Journal of Pediatric Genetics, 5(02), 116-123.
Frantzen, C., Links, T. P., & Giles, R. H. (2012). von Hippel-Lindau disease. GeneReviews. Seattle (WA): University of Washington, Seattle.
Guerrero-Galindo, R., Castrejón, E., Aguirre-Portillo, L., Cervantes-Michel, J. L., & Espejo-Plascencia, I. (2012). Intramedullary hemangioblastoma. Archivos de Neurociencias, 17(4), 247-249.
Kanno, H., Kobayashi, N., & Nakanowatari, S. (2014). Pathological and Clinical Features and Management of Central Nervous System Hemangioblastomas in von Hippel-Lindau Disease. Journal of kidney cancer and VHL, 1(4), 46–55. https://doi.org/10.15586/jkcvhl.2014.12
Koo, H. W., Park, J. E., Cha, J., Kim, D. J., Kang, S. G., Lim, S. C., & Suh, D. C. (2016). Hemangioblastomas with leptomeningeal dissemination: Case series and review of the literature. Acta neurochirurgica, 158(6), 1169-1178.
Lonser, R. R., Glenn, G. M., Walther, M., Chew, E. Y., Libutti, S. K., Linehan, W. M., & Oldfield, E. H. (2003). von Hippel-Lindau disease. The Lancet, 361(9374), 2059-2067.
Maher, E. R., Neumann, H. P., & Richard, S. (2011). von Hippel–Lindau disease: A clinical and scientific review. European Journal of Human Genetics, 19(6), 617-623.
Malleo, G. (2010). Pancreatic cystic tumours: when to resect, when to observe. European review for medical and pharmacological sciences, 14, 395-406.
Nordstrom‐O'Brien, M., van der Luijt, R. B., van Rooijen, E., van den Ouweland, A. M., Majoor‐Krakauer, D. F., Lolkema, M. P., ... & Giles, R. H. (2010). Genetic analysis of von Hippel‐Lindau disease. Human mutation, 31(5), 521-537.
Patel, N. P., Robinson, T. M., Lesley, W. S., Garrett, D., Shan, Y., & Huang, J. H. (2019). Hemangioblastoma Retromedular Imitando um Aneurisma da Artéria Cerebelar Inferior Posterior: Relato de Caso e Revisão de Literatura. Neurocirurgia Mundial, 122, 165–170. https://doi.org/10.1016/j.wneu.2018.10.188
Pavesi, G., Feletti, A., Berlucchi, S., Opocher, G., Martella, M., Murgia, A., & Scienza, R. (2008). Neurosurgical treatment of von Hippel-Lindau-associated hemangioblastomas: benefits, risks and outcome. Journal of neurosurgical sciences, 52(2), 29-36.
Sampaio, D. B., Lima, W. P. de, Matias, I. de S., Saraiva, I. S., Ferreira, M. L., Ramos, V. M., & Ribeiro, P. J. T. (2022). Treatment of hemangiomas in the head and neck region: integrative literature review. Research, Society and Development, 11(1), e43811125236. https://doi.org/10.33448/rsd-v11i1.25236
Seizinger, B. R., Rouleau, G. A., Ozelius, L. J., Lane, A. H., Farmer, G. E., Lamiell, J. M., ... & Gusella, J. F. (1988). Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature, 332(6161), 268-269.
Wanebo, J. E., Lonser, R. R., Glenn, G. M., & Oldfield, E. H. (2003). The natural history of hemangioblastomas of the central nervous system in patients with von Hippel—Lindau disease. Journal of neurosurgery, 98(1), 82-94.
Wang, Q., Meng, S., Cheng, J., Zhang, S., Ju, Y., Fang, Y., ... & Hui, X. (2020). Central nervous system hemangioblastomas: An age-stratified analysis. Clinical Neurology and Neurosurgery, 199, 106281.
Westwick, H. J., Giguère, J. F., & Shamji, M. F. (2016). Incidence and prognosis of spinal hemangioblastoma: a surveillance epidemiology and end results study. Neuroepidemiology, 46(1), 14-23.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Gustavo Soares Gomes Barros Fonseca; Vivianne Maria Laranjeiras Monte Freire; Lais Lima Bonfim; Elana Cristina da Silva Penha; João Victor Araújo Guimarães; Raphael Erick Lima Pereira; Gabriel de Sousa Macedo; Filipe Augusto Lopes Cajubá de Britto; Letícia Muniz de Abreu Murad; Alessandra do Rosário Brito; Lara Letícia Teixeira Reis; Amanda Cordeiro Santos; Agostinho Rodrigues Mesquita Neto; Julianne Souza Prazeres; Luiza Mariana Batista Lima Cunha; Ana Vitória Feitosa Barroso Maia; Carolynne Weba da Silva; Fernando de Abreu Borges; Monaliza Brito de Almeida; Samantha Cunha Vieira; Isabela Coelho Brito Soares; Liciana Tapety Sá; Lucca Adriano Pereira; Thalita Martins Bezerra; Ivana Mota Soares; Rebeca Machado Castro Sousa; Maria Beatriz Celedonio Coelho; Felipe Ramos Caldeira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
